Unusually Long Survival of a 67-Year-Old Patient with Near-Tetraploid Acute Myeloid Leukemia M0 without Erythroblastic and Megakaryocytic Dysplasia

Patients with near-tetraploid acute myeloid leukemia (NT-AML) typically have poor survival. We present the case of a 67-year-old Caucasian male with NT-AML M0 who had an unusually long first complete remission of 51 months and an overall survival of 80 months. The only characteristic distinguishing him from other previously described patients with NT-AML was the absence of erythroblastic and/or megakaryocytic dysplasia (EMD) at diagnosis. Molecular-genetic testing for AML fusion transcripts associated with a favorable prognosis (PML/RARα,AML1/ETO, and CBFβ/MYH11) were negative, as were other prognostic markers like MLL-PTD,FLT3-ITD, or mutations of FLT3-D835,NPM1, or CEBPA. Expression studies of ERG,MN1, and EVI1 revealed overexpression of ERG only. The absence of EMD may be a useful prognostic/diagnostic feature of this new rare subtype of NT-AML.

[1]  K. Anderson,et al.  Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.

[2]  James R. Downing,et al.  Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells , 2010, Nature.

[3]  A. Chapelle,et al.  Polyploidy of the bone marrow. , 2009 .

[4]  J. Starý,et al.  Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome , 2009, Leukemia & lymphoma.

[5]  J. Merker,et al.  Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. , 2008, Blood.

[6]  M. Caligiuri,et al.  Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Preudhomme,et al.  Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients. , 2008, Clinical and laboratory haematology.

[8]  H. Klamová,et al.  CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma. , 2008, Blood cells, molecules & diseases.

[9]  M. Balbín,et al.  A new type of NPM1 gene mutation in AML leading to a C-terminal truncated protein , 2007, Leukemia.

[10]  K. Döhner,et al.  High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. , 2006, Blood.

[11]  T. Haferlach,et al.  Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases , 2006, Leukemia.

[12]  M. Caligiuri,et al.  Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Sandya Liyanarachchi,et al.  Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Haas,et al.  Erythroblastic and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories. , 2000, Leukemia research.

[15]  J. Jelinek,et al.  Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors. , 1998, Leukemia research.

[16]  Secker-Walker,et al.  Trisomy 13 and myeloid malignancy — characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey , 1998, British journal of haematology.

[17]  M. Caligiuri,et al.  Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. , 1996, Cancer research.

[18]  L. Contis,et al.  Near-tetraploidy in adult acute myelogenous leukemia. , 1996, Cancer genetics and cytogenetics.

[19]  P. Greenberg,et al.  Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. , 1994, Blood.

[20]  A. Jirásek,et al.  Near-tetraploid poorly differentiated acute myeloid leukemia M0 diagnosed by short-term cultures with a phorbol ester TPA. , 1994, Leukemia research.

[21]  H. Gralnick,et al.  Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) , 1991, British journal of haematology.

[22]  D. Catovsky,et al.  Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia , 1987, British journal of haematology.

[23]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[24]  Z. Zemanová,et al.  [Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7]. , 2010, Vnitrni lekarstvi.

[25]  H. Qiu,et al.  Tetraploid clone characterized by two t(15;17) in five cases of acute promyelocytic leukemia. , 2009, Cancer genetics and cytogenetics.

[26]  K. Michalová,et al.  Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia. , 2007, Neoplasma.

[27]  S. Matsui,et al.  Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. , 2004, Cancer genetics and cytogenetics.

[28]  M. Yao,et al.  Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23 , 2002, Leukemia.

[29]  P. Greenberg,et al.  Expression of EVIl in Myelodysplastic Syndromes and Other Hematologic Malignancies Without 3 q 26 Translocations , 2002 .

[30]  T. Haas,et al.  Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia? , 2000, Neoplasma.

[31]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .